{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:18:15Z","timestamp":1792052295510,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The clinical course and serological profile of the late-age onset systemic sclerosis (LAO SSc) and the early-age onset SSc (EAO SSc) was compared. The study enrolled 157 patients that fulfilled the American College of Rheumatology (ACR)\/European League against Rheumatism (EULAR) classification criteria for systemic sclerosis (SSc). Among them, 69 had diffuse cutaneous SSc (dcSSc) and 88 limited cutaneous SSc (lcSSc). Within this population, 39 patients developed the disease over the age of 60\u00a0years old (LAO SSc) and 118 prior to that age (EAO SSc). The subtype of SSc, the incidence of internal organ involvement, the prevalence of malignancy, mortality, and serological profile were compared between both groups. The LAO SSc was observed in 39 of total 157 patients with SSc and exhibited a notably higher prevalence of pulmonary arterial hypertension (<jats:italic>p<\/jats:italic>\u2009=\u20090.014), heart involvement (<jats:italic>p<\/jats:italic>\u2009=\u20090.0014), and renal involvement (<jats:italic>p<\/jats:italic>\u2009=\u20090.0002). The occurrence of arthralgias was less common in the LAO SSc group (<jats:italic>p<\/jats:italic>\u2009=\u20090.02) than in the EAO SSc group. Furthermore, in the LAO SSc group, the prevalence of anti \u2013RNA polymerase III antibodies (<jats:italic>p<\/jats:italic>\u2009=\u20090.008) and antiPM\/Scl antibodies (<jats:italic>p<\/jats:italic>\u2009=\u20090.048) were significantly lower than in the EAO SSc group. On the other hand, higher anti-Th\/To antibody levels (<jats:italic>p<\/jats:italic>\u2009=\u20090.014) were recorded in the LAO SSc group. Approximately 25% of SSc patients experienced a delayed onset of the disease after the age of 60\u00a0years old. Some clinical and serological features of late-onset SSc were markedly different from that in early-onset disease. Particularly noteworthy is the fact that involvement of internal organs such as heart and kidneys, as well as pulmonary arterial hypertension were much more often observed among patients with LAO SSc which in our suggestion may be referred to age-related co-morbidities.<jats:table-wrap><jats:table><jats:tbody>\n                    <jats:tr>\n                      <jats:td colspan=\"2\"><jats:bold>Key Points<\/jats:bold><jats:italic>\u2022 Significant differences in clinical and serological profile of the disease were found between late-age onset (LAO) and early-age onset (EAO) SSc.<\/jats:italic><jats:italic>\u2022 Incidence of dcSSc as well as prevalence of anti\u2013RNA polymerase III and anti-PM\/Scl antibodies were found to be lower in patients over 60\u00a0years old compared to those before 60, but regardless of the age of the disease onset.<\/jats:italic><jats:italic>\u2022 Internal organ morbidity, notably pulmonary arterial hypertension, renal impairment and heart disease were significantly more common in elder SSc patients as well as in those with late disease onset.<\/jats:italic><jats:italic>\u2022 These findings may suggest an impact of age-related co-morbidities on the course of late-age onset SSc.<\/jats:italic><\/jats:td>\n                    <\/jats:tr>\n                  <\/jats:tbody><\/jats:table><\/jats:table-wrap><\/jats:p>","DOI":"10.1007\/s10067-024-07025-z","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T05:01:38Z","timestamp":1718946098000},"page":"2565-2572","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Late-age onset systemic sclerosis\u2014clinical and serological characteristics"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2193-7778","authenticated-orcid":false,"given":"Ewa","family":"Wielosz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Wi\u0105k-Walerowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"\u0141y\u015b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Lipska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Dryglewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Majdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"issue":"6","key":"7025_CR1","doi-asserted-by":"publisher","first-page":"e0269661","DOI":"10.1371\/journal.pone.0269661","volume":"17","author":"T Nakajima","year":"2022","unstructured":"Nakajima T, Nakano S et al (2022) Nailfold capillary patterns correlate with age, gender, lifestyle habits, and fingertip temperature. PLoS ONE 17(6):e0269661","journal-title":"PLoS ONE"},{"issue":"4","key":"7025_CR2","doi-asserted-by":"publisher","first-page":"e12447","DOI":"10.1111\/micc.12447","volume":"25","author":"M Cutolo","year":"2018","unstructured":"Cutolo M, Trombetta A, Melsens K et al (2018) Automated assessment of absolute nailfold capillary number on videocapillaroscopic images: proof of principle and validation in systemic sclerosis. Microcirculation 25(4):e12447","journal-title":"Microcirculation"},{"issue":"Suppln1","key":"7025_CR3","first-page":"e000782","volume":"4","author":"V Smith","year":"2018","unstructured":"Smith V, Scire C, Talarico R, Airo P et al (2018) Systemic sclerosis: state of the art on clinical practice guidelines. RMD Open 4(Suppln1):e000782 (Published 2018 Oct 18)","journal-title":"RMD Open"},{"issue":"4","key":"7025_CR4","first-page":"76","volume":"113","author":"R Apipattarakul","year":"2018","unstructured":"Apipattarakul R, Foocharoen C, Netwijitpan S, Mahakkanukrauh A, Suwannnaroj S, Limpawattana P et al (2018) Clinical characteristics and mortality rate of Thai elderly-onset systemic sclerosis. Clin Exp Rheumatol 113(4):76\u201381","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"7025_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/MD.0000000000000018","volume":"93","author":"MA Alba","year":"2014","unstructured":"Alba MA, Velasco C, Sime\u00f3n CP, Fonollosa V, Trapiella L, Egurbide MV et al (2014) Early- versus late-onset systemic sclerosis: differences in clinical presentation and outcome in 1037 patients. Medicine (Baltimore) 93(2):73\u201381","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"7025_CR6","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3899\/jrheum.100956","volume":"38","author":"RL Manno","year":"2011","unstructured":"Manno RL, Wigley FM, Gelber AC, Hummers LK (2011) Late-age onset systemic sclerosis. J Rheumatol 38(7):1317\u20132","journal-title":"J Rheumatol"},{"issue":"8","key":"7025_CR7","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/art.11073","volume":"48","author":"MD Mayes","year":"2003","unstructured":"Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ et al (2003) Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 48(8):2246\u20132255","journal-title":"Arthritis Rheum"},{"issue":"10373","key":"7025_CR8","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","volume":"401","author":"ER Volkmann","year":"2023","unstructured":"Volkmann ER, Andr\u00e9asson K, Smith V (2023) Systemic sclerosis. The Lancet 401(10373):304\u2013318","journal-title":"The Lancet"},{"issue":"3","key":"7025_CR9","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s12016-022-08946-w","volume":"64","author":"I Cavazzana","year":"2023","unstructured":"Cavazzana I, Vojinovic T, Airo\u2019 P, Fredi M, Ceribelli A, Pedretti E et al (2023) Systemic sclerosis-specific antibodies: novel and classical biomarkers. Clin Rev Allergy Immunol 64(3):412\u201330","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"7025_CR10","first-page":"10","volume":"28","author":"HH Weng","year":"2010","unstructured":"Weng HH, Ranganath VK, Oh M, Park GS, Khanna D, Clements PJ et al (2010) Differences in presentation of younger and older systemic sclerosis patients in clinical trials. Clin Exp Rheumatol 28(5):10\u201314","journal-title":"Clin Exp Rheumatol"},{"key":"7025_CR11","doi-asserted-by":"publisher","first-page":"152197","DOI":"10.1016\/j.semarthrit.2023.152197","volume":"60","author":"A Adrovic","year":"2023","unstructured":"Adrovic A, Karatemiz G, Esatoglu SN, Yildiz M, Sahin S, Barut K et al (2023) Juvenile and adult-onset scleroderma: different clinical phenotypes. Semin Arthritis Rheum 60:152197","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"7025_CR12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1532-5415.1971.tb02625.x","volume":"19","author":"HM Hodkinson","year":"1971","unstructured":"Hodkinson HM (1971) Scleroderma in elderly, with special reference to the CREST syndrome. J Am Geriatr Soc Mar 19(3):224\u2013228","journal-title":"J Am Geriatr Soc Mar"},{"issue":"6","key":"7025_CR13","doi-asserted-by":"publisher","first-page":"103330","DOI":"10.1016\/j.autrev.2023.103330","volume":"22","author":"M Scheen","year":"2023","unstructured":"Scheen M, Dominati A, Olivier V, Nasr S, De Seigneux S, Mekinian A et al (2023) Renal involvement in systemic sclerosis. Autoimmun Rev. 22(6):103330","journal-title":"Autoimmun Rev."},{"issue":"6","key":"7025_CR14","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s10067-005-0177-y","volume":"25","author":"CT Derk","year":"2006","unstructured":"Derk CT, Artlett CM, Jimenez SA (2006) Morbidity and mortality of patients diagnosed with systemic sclerosis after the age of 75: a nested case-control study. Clin Rheumatol Nov 25(6):831\u2013834","journal-title":"Clin Rheumatol Nov"},{"issue":"4","key":"7025_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/BF02283102","volume":"11","author":"L Czirjak","year":"1992","unstructured":"Czirjak L, Nagy Z, Szegedi G (1992) Systemic sclerosis in the elderly. Clin Rhematol Dec 11(4):483\u2013485","journal-title":"Clin Rhematol Dec"},{"issue":"11","key":"7025_CR16","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1093\/rheumatology\/keaa127","volume":"59","author":"P Moinzadeh","year":"2020","unstructured":"Moinzadeh P, Kuhr K, Siegert E, Mueller-Ladner U, Riemekasten G, G\u00fcnther C et al (2020) Older age onset of systemic sclerosis \u2013 accelerated disease progression in all disease subsets. Rheumatology 59(11):3380\u20139","journal-title":"Rheumatology"},{"key":"7025_CR17","doi-asserted-by":"publisher","unstructured":"Erdogan M, Kilickiran Avci B, Ebren C, Ersoy Y, Ongen Z, Ongen G et al (2024) Screening for pulmonary arterial hypertension in patients with systemic sclerosis in the era of new pulmonary arterial hypertension definitions. Clin Exp\u00a0Rheumatol. https:\/\/doi.org\/10.55563\/clinexprheumatol\/gzo4r2","DOI":"10.55563\/clinexprheumatol\/gzo4r2"},{"key":"7025_CR18","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 72:1747\u20131755","journal-title":"Ann Rheum Dis"},{"key":"7025_CR19","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleishmajer R (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202\u2013204","journal-title":"J Rheumatol"},{"key":"7025_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/rheumatology\/keq321","volume":"50","author":"T H\u00fcgle","year":"2011","unstructured":"H\u00fcgle T, Schuetz P, Daikeler T, Tyndall A, Matucci-Cerinic M, Walker UA et al (2011) Late-onset systemic sclerosis\u2013a systematic survey of the EULAR scleroderma trials and research group database. Rheumatology (Oxford) 50:161\u2013165","journal-title":"Rheumatology (Oxford)"},{"key":"7025_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.annder.2017.10.016","volume":"145","author":"A Achille","year":"2018","unstructured":"Achille A, Journeau L, Espitia O, Connault J, Espitia-Thibault A, Durant C et al (2018) Late-onset systemic sclerosis: a retrospective study of 27 patients diagnosed after the age of 70. Ann Dermatol Venereol 145:166\u2013172","journal-title":"Ann Dermatol Venereol"},{"key":"7025_CR22","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/1756-185X.13307","volume":"21","author":"S Wangkaew","year":"2018","unstructured":"Wangkaew S, Phiriyakrit P, Sawangduan V, Prasertwittayakij N, Euathrongchit J (2018) Differences in clinical presentation and incidence of cardiopulmonary involvement in late-onset versus early-onset systemic sclerosis: inception cohort study. Int J Rheum Dis 21:1082\u20131092","journal-title":"Int J Rheum Dis"},{"key":"7025_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/03009742.2018.1459830","volume":"48","author":"PE Carreira","year":"2019","unstructured":"Carreira PE, Carmona L, Joven BE, Loza E, Andr\u00e9u JL, Riemekasten G et al (2019) Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database. Scand J Rheumatol 48:42\u201351","journal-title":"Scand J Rheumatol"},{"key":"7025_CR24","doi-asserted-by":"publisher","first-page":"152033","DOI":"10.1016\/j.semarthrit.2022.152033","volume":"55","author":"A Gonz\u00e1lez Garc\u00eda","year":"2022","unstructured":"Gonz\u00e1lez Garc\u00eda A, Fabregate M, Manzano L, Guill\u00e9n del Castillo A, Rubio Rivas M, Argibay A et al (2022) Left ventricular diastolic dysfunction in systemic sclerosis: clinical, immunological and survival differences in the Spanish RESCLE registry. Semin Arthritis Rheum. 55:152033","journal-title":"Semin Arthritis Rheum."},{"key":"7025_CR25","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s10067-009-1188-x","volume":"28","author":"E Wielosz","year":"2009","unstructured":"Wielosz E, Dryglewska M, Majdan M (2009) Antiphospholipid antibodies and kidney involvement in patients with systemic sclerosis. Clin Rheumatol 28:955\u2013959","journal-title":"Clin Rheumatol"},{"key":"7025_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12959-022-00409-8","volume":"20","author":"W-Ch Yao","year":"2022","unstructured":"Yao W-Ch, Leong K-H, Chiu L-T et al (2022) The trend in the incidence and thrombosis-related comorbidities of antiphospholipid syndrome a 14-year nationwide population-based study. Thrombosis J 20:50","journal-title":"Thrombosis J"},{"issue":"5","key":"7025_CR27","first-page":"1004","volume":"33","author":"K Scalapino","year":"2006","unstructured":"Scalapino K, Arkachaisri T, Lucas M, Fertig N, Helfrich DJ, Londino AV Jr et al (2006) Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. J Rheumatol 33(5):1004\u20131013","journal-title":"J Rheumatol"},{"issue":"7","key":"7025_CR28","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1093\/rheumatology\/keac639","volume":"62","author":"A Ramahi","year":"2023","unstructured":"Ramahi A, Lescoat A, Roofeh D, Nagaraja V, Namas R, Huang S et al (2023) Risk factors for lung function decline in systemic sclerosis-associated interstitial lung disease in a large single-centre cohort. Rheumatology 62(7):2501\u20139","journal-title":"Rheumatology"},{"issue":"11","key":"7025_CR29","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.3390\/life12111781","volume":"12","author":"M Colaci","year":"2022","unstructured":"Colaci M, Aprile ML, Sambataro D, Sambataro G, Malatino L (2022) Systemic sclerosis and idiopathic portal hypertension: report of a case and review of the literature. Life 12(11):1781","journal-title":"Life"},{"key":"7025_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13075-018-1771-0","volume":"20","author":"S Panopoulos","year":"2018","unstructured":"Panopoulos S, Tektonidou M, Drosos AA, Liossis SN, Dimitroulas T, Garyfallos A et al (2018) Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study. Arthritis Res Ther 20:267\u2013277","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"7025_CR31","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1093\/rheumatology\/keab735","volume":"61","author":"S Hoa","year":"2022","unstructured":"Hoa S, Lazizi S, Baron M, Wang M, Fritzler MJ, Hudson M et al (2022) Association between autoantibodies in systemic sclerosis and cancer in a national registry. Rheumatology 61(7):2905\u201314","journal-title":"Rheumatology"},{"issue":"11","key":"7025_CR32","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/acr.24076","volume":"72","author":"K Morrisroe","year":"2020","unstructured":"Morrisroe K, Hansen D, Huq M, Stevens W, Sahhar J, Ngian GS et al (2020) Incidence, risk factors, and outcomes of cancer in systemic sclerosis. Arthritis Care Res 72(11):1625\u201335","journal-title":"Arthritis Care Res"},{"key":"7025_CR33","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2147\/JMDH.S295478","volume":"15","author":"N Farina","year":"2022","unstructured":"Farina N, Benanti G, De Luca G, Palmisano A, Peretto G, Tomassetti S et al (2022) The role of the multidisciplinary health care team in the management of patients with systemic sclerosis. J Multidiscip Healthc 15:815\u201324","journal-title":"J Multidiscip Healthc"}],"updated-by":[{"DOI":"10.1007\/s10067-024-07090-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000}}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07025-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07025-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07025-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T08:10:17Z","timestamp":1723795817000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07025-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["7025"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07025-z","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10067-024-07090-4","asserted-by":"object"}]},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,21]]},"assertion":[{"value":"11 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10067-024-07090-4","URL":"https:\/\/doi.org\/10.1007\/s10067-024-07090-4","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}